STOCK TITAN

Natera (NASDAQ: NTRA) director Chapman sells 135 shares in 10b5-1 trade

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. director Rowan E Chapman sold 135 shares of Common Stock on July 15, 2026 at an average price of $274.82 per share. The sale was effected under a Rule 10b5-1 trading plan adopted on December 12, 2025, leaving Chapman with 4,663 shares held directly.

Positive

  • None.

Negative

  • None.
Insider Chapman Rowan E
Role Director
Sold 135 shs ($37K)
Type Security Shares Price Value
Sale Common Stock F1 135 $274.82 $37K
Holdings After Transaction: Common Stock — 4,663 shares (Direct)
Footnotes (1)
  1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Shares sold 135 shares Common Stock sale on July 15, 2026
Sale price $274.82 per share Average price for Common Stock sold
Shares held after sale 4,663 shares Direct ownership following the transaction
10b5-1 plan adoption date December 12, 2025 Rule 10b5-1 trading plan covering this sale
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
Common Stock financial
"security_title: Common Stock reported as non-derivative"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Natera (NTRA) report on July 15, 2026?

Natera reported that director Rowan E Chapman sold 135 shares of its Common Stock on July 15, 2026. The transaction was categorized as a sale in an open market or private transaction and reported on a Form 4 filing.

How many Natera (NTRA) shares did Rowan E Chapman sell and at what price?

Rowan E Chapman sold 135 shares of Natera Common Stock at an average price of $274.82 per share. This sale was reported as a non-derivative transaction and reflects a routine trading activity disclosed to the SEC.

Was the Natera (NTRA) insider sale by Rowan E Chapman under a Rule 10b5-1 plan?

Yes. The sale of Natera shares was executed under a Rule 10b5-1 trading plan adopted by Rowan E Chapman on December 12, 2025. Such pre-arranged plans allow insiders to systematically sell shares according to preset instructions.

How many Natera (NTRA) shares does Rowan E Chapman own after the reported sale?

After selling 135 shares, Rowan E Chapman directly owns 4,663 shares of Natera Common Stock. This figure reflects the total direct holdings following the July 15, 2026 transaction as reported in the Form 4 filing.

What type of security was involved in the Natera (NTRA) insider transaction?

The insider transaction involved Natera’s Common Stock as a non-derivative security. No derivative securities such as options or warrants were reported in this Form 4, and there were no derivative transactions disclosed for this event.

How is the Natera (NTRA) insider sale by Rowan E Chapman classified?

The transaction is classified as a sale in open market or private transaction, coded as “S” on Form 4. It represents a direct disposition of Common Stock under a pre-established Rule 10b5-1 trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chapman Rowan E

(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TEXAS 78753

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/15/2026S135(1)D$274.824,663D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
/s/ Tami Chen, Attorney-in-Fact07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)